 |
|
常见的血液肿瘤主要包括各类白血病、多发性脊髓瘤以及恶性淋巴瘤。急性白血病占常见恶性肿瘤的第八位，淋巴瘤也是在前十位，并且发病率逐年升高，多发性骨髓瘤的整个发病率在血液恶性肿瘤里面占10%。
以下产品可用于多种常见血液肿瘤研究，急性淋巴细胞白血病（Acute Lymphoblastic Leukemia (ALL)是一种起源于淋巴细胞的B系或T系细胞在骨髓内异常增生的恶性肿瘤疾病。异常增生的原始细胞可在骨髓聚集并抑制正常造血功能，同时也可侵及骨髓外的组织，如脑膜、淋巴结、性腺、肝等。急性髓细胞白血病(acute myelocytic leukemia，AML)包括所有非淋巴细胞来源的急性白血病，是多能干细胞或已轻度分化的前体细胞核型发生突变所形成的一类疾病是造血系统的克隆性恶性疾病。淋巴瘤（Lymphoma）是起源于淋巴造血系统的恶性肿瘤，主要表现为无痛性淋巴结肿大，肝脾肿大。
相关产品列表： |
|
急性淋巴细胞白血病相关抗体 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
CD3 |
NBP2-25186 |
Ms |
OKT3 |
Hu |
FLOW |
|
CD19 |
NBP2-25196 |
Ms |
CD19 |
Hu |
FLOW, IHC |
|
IL2RA/CD25 |
NBP2-27425 |
Rt |
PC61 |
Ms |
FLOW |
|
CD44 |
NBP1-47386 |
Ms |
8E2F3 |
Hu, Ms, Ca, Rb, Eq |
WB, ELISA, FLOW, ICC/IF, IHC, IHC-P |
|
Notch-1 |
NB100-78486 |
Ms |
mN1A |
Hu, Ms |
WB, FLOW, ICC/IF, IHC, IHC-P, IP | |
|
急性髓细胞样白血病相关抗体 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
c-Kit |
NB100-77477 |
Rt |
2B8 |
Hu, Ms |
FLOW, IHC, IHC-Fr, IP |
|
ETV6/Tel |
NBP1-80695 |
Rb |
poly |
Hu, Rt |
WB, ICC/IF, IHC, IHC-P |
|
Flt3/CD135 |
NBP1-43352 |
Rt |
A2F10 |
Ms |
FLOW, Func, IP |
|
Nucleophosmin |
NB110-61646 |
Rb |
poly |
Hu, Ms |
WB, FLOW, ICC/IF, IHC, IHC-P, IP |
|
RUNX1 |
NB100-2044 |
Rb |
poly |
Hu, Ms |
WB | |
|
淋巴瘤相关抗体 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
Bcl2 |
NB100-56098 |
Rb |
poly |
Hu, Bv, Ca, Fe |
WB, IHC, IHC-P, IP |
|
CD5 |
NBP2-02690 |
Ms |
7A7 |
Hu |
WB, FLOW, ICC/IF, IHC, IHC-P |
|
CD10 |
NBP1-47356 |
Ms |
2A1H5E1 |
Hu |
WB, ELISA, ICC/IF, IHC, IHC-P |
|
CD15 |
NBP1-28441 |
Ms |
28 |
Hu |
FLOW, IHC, IHC-Fr, IP |
|
CD30 |
NBP2-29425 |
Ms |
CD30/412 |
Hu |
ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P | |
|
多发性骨髓瘤相关抗体 |
|
Antibody |
Catalog No. |
Host |
Clone |
Reactivity |
Tested Application/s |
|
beta 2 microglobulin |
NB500-317 |
Ms |
B2M-01 |
Hu |
WB, ELISA, FLOW, IHC, IHC-P, IP, RIA |
|
CD38 |
NBP2-25250 |
Ms |
1G7F4 |
Hu, Ms |
WB, IHC, IHC-P |
|
CD56 + NCAM-1 |
NBP2-15184 |
Ms |
123C3 |
Hu, Rt, Ze |
WB, ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P, IP |
|
IL-6 |
NB600-1131 |
Rb |
poly |
Hu, Ms, Rt |
WB, ELISA, ICC/IF, IHC, IHC-P, IP |
|
Syndecan 1 |
NBP1-54523 |
Ms |
MI15 |
Hu |
FLOW, ICC/IF, IHC, IHC-P | |
|
|
|
CD3 NBP02-25186 |
CD10 NBP1-47356 |
IL-6 NB600-1131 |
|
| 关注Novus疾病研究（http://www.novusbio.com/Hematological-Cancers ）查询更多与血液肿瘤相关的基因、通路、文献及产品等信息。 |
